ACT |
Adoptive Cellular Therapy |
ADAM17 |
A Disintegrin And Metalloproteinase 17 |
ADCC |
Antibody-Dependent Cellular Cytotoxicity |
APC |
Antigen-Presenting Cell |
APN |
Adiponectin |
Alox5 |
Arachidonate 5-Lipoxygenase |
bFGF |
Basic Fibroblast Growth Factor |
Breg |
Regulatory B Lymphocyte |
CAA |
Cancer-Associated Adipocyte |
CAF |
Cancer-Associated Fibroblast |
CAR |
Chimeric Antigen Receptor |
CAR-M |
Chimeric Antigen Receptor Macrophage |
CAR-NK |
Chimeric Antigen Receptor Natural Killer |
CAR-T |
Chimeric Antigen Receptor T Cell Therapy |
CAR-Neu |
Chimeric Antigen Receptors Neutrophils |
CCL |
C-C Motif Chemokine Ligand |
CD |
Cluster of Differentiation |
CIC |
Circulating Immune Complex |
CIK |
Cytokine-Induced Killer |
CPI |
Checkpoint Inhibitor |
CSF1R |
Colony-Stimulating Factor 1 Receptor |
CTL |
Cytotoxic T Lymphocyte |
CTLA-4 |
Cytotoxic T Lymphocyte Antigen 4 |
CXCL |
C-X-C Motif Chemokine Ligand |
CXCR1/CXCR2 |
CXC Chemokine Receptor 1/2 |
DAMP |
Damage-Associated Molecular Pattern |
DC |
Dendritic Cell |
EC |
Endothelial Cell |
EGF |
Epidermal Growth Factor |
EndMT |
Endothelial to Mesenchymal Transition |
eTreg |
Effector Regulatory Cell |
FcR |
Fc Receptor |
FGF |
Fibroblast Growth Factor |
FDA |
Food and Drug Administration |
GNR |
Gold Nanorod |
GM-CSF |
Granulocyte-Macrophage Colony-Stimulating Factor |
GVHD |
Graft-Versus-Host Disease |
HER2 |
Human Epidermal Growth Factor Receptor 2 |
HGF |
Hepatocyte Growth Factor |
HIF-1 |
Hypoxia-Inducible Factor 1 |
HLA |
Human Leukocyte Antigen |
IDO |
Indoleamine 2,3-Dioxygenase |
IDO1 |
Indoleamine 2,3-Dioxygenase 1 |
IFN |
Interferon |
IFNα |
Interferon Alpha |
IFN-γ |
Interferon Gamma |
IGF |
Insulin-Like Growth Factor |
IL |
Interleukin |
IL-4 |
Interleukin 4 |
IL-10 |
Interleukin 10 |
IL-12 |
Interleukin 12 |
IL-13 |
Interleukin 13 |
IL-15 |
Interleukin 15 |
IL-18 |
Interleukin 18 |
IL-35 |
Interleukin 35 |
iNOS |
Inducible Nitric Oxide Synthase |
LPS |
Lipopolysaccharide |
MDC |
Macrophage–Drug Conjugate |
MDSC |
Myeloid-Derived Suppressor Cell |
MHC |
Major Histocompatibility Complex |
MMP |
Matrix Metalloproteinase |
MMP9 |
Matrix Metalloproteinase 9 |
Mφ |
Macrophage |
MPO |
Myeloperoxidase |
Nφ |
Neutrophil |
NET |
Neutrophil Extracellular Trap |
NE |
Neutrophil Elastase |
NKG2D |
Natural Killer Group 2 Member D |
NK |
Natural Killer |
NO |
Nitric Oxide |
NP |
Nanoparticle |
OLFM4 |
Olfactomedin 4 |
PAMP |
Pathogen-Associated Molecular Pattern |
PD-1 |
Programmed Cell Death Protein 1 |
PD-L1 |
Programmed Death Ligand 1 |
PDGF |
Platelet-Derived Growth Factor |
PGE2 |
Prostaglandin E2 |
pDC |
Plasmacytoid Dendritic Cell |
PlGF |
Placental Growth Factor |
RNS |
Reactive Nitrogen Species |
ROBO-1 |
Roundabout Guidance Receptor 1 |
ROS |
Reactive Oxygen Species |
scFv |
Single-Chain Variable Fragment |
siRNA |
Small Interfering RNA |
TAM |
Tumor-Associated Macrophage |
Tc |
Cytotoxic T Cell |
TCR |
T Cell Receptor |
TEC |
Tumor-Associated Endothelial Cell |
Tfh |
T Follicular Helper |
TGF |
Transforming Growth Factor |
TGF-β |
Transforming Growth Factor Beta |
Th |
T Helper |
TIL |
Tumor-Infiltrating Lymphocyte |
TME |
Tumor Microenvironment |
TNF |
Tumor Necrosis Factor |
TNF-α |
Tumor Necrosis Factor Alpha |
TRAIL |
TNF-Related Apoptosis-Inducing Ligand |
TRAIN |
TRAnsfer of Iron-binding protein |
TRC |
T Cell Receptor |
TRM |
Tissue-Resident Macrophage |
Treg |
Regulatory T Cell |
tTreg |
Thymus-Derived Treg Cell |
TRUCK |
T cells Redirected for Universal Cytokine Killing |
VEGF |
Vascular Endothelial Growth Factor |
WAT |
White Adipose Tissue |